X4 Pharmaceuticals (XFOR) Tops Q4 EPS by 56c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q4 EPS of $0.29, $0.56 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Shipping stocks on fire — but cracks are forming in the rate rally
• Vitesse Energy closes $26M Denver-Julesburg Basin acquisition
• Halozyme proposes $1.05 billion convertible notes offering